Microbix Biosystems Inc. (MBX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Microbix Biosystems Inc. (MBX) has a cash flow conversion efficiency ratio of -0.012x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-307.77K ≈ $-222.64K USD) by net assets (CA$25.14 Million ≈ $18.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Microbix Biosystems Inc.'s balance sheet to measure how much of total assets are equity-financed.
Microbix Biosystems Inc. - Cash Flow Conversion Efficiency Trend (1997–2025)
This chart illustrates how Microbix Biosystems Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Microbix Biosystems Inc. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Microbix Biosystems Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Microbix Biosystems Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Uvre Ltd
AU:UVA
|
-0.248x |
|
Sangsin Brake
KO:041650
|
-0.048x |
|
Daegu Dept Sto
KO:006370
|
-0.045x |
|
Bellway PLC
LSE:BWY
|
-0.001x |
|
EMB Mission Bound AB (publ)
ST:NAVIGO-STAM
|
0.033x |
|
Fade Gida Yatirim Sanayi Ticaret As
IS:FADE
|
0.001x |
|
Santa Fe Minerals Ltd
AU:SFM
|
0.000x |
|
IL&FS Investment Managers Limited
NSE:IVC
|
-0.037x |
Annual Cash Flow Conversion Efficiency for Microbix Biosystems Inc. (1997–2025)
The table below shows the annual cash flow conversion efficiency of Microbix Biosystems Inc. from 1997 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Microbix Biosystems Inc..
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | CA$27.79 Million ≈ $20.10 Million |
CA$-80.29K ≈ $-58.08K |
-0.003x | -101.88% |
| 2024-09-30 | CA$28.30 Million ≈ $20.47 Million |
CA$4.35 Million ≈ $3.15 Million |
0.154x | +445.65% |
| 2023-09-30 | CA$24.62 Million ≈ $17.81 Million |
CA$-1.09 Million ≈ $-791.79K |
-0.044x | -131.99% |
| 2022-09-30 | CA$24.94 Million ≈ $18.04 Million |
CA$3.47 Million ≈ $2.51 Million |
0.139x | +22.39% |
| 2021-09-30 | CA$18.56 Million ≈ $13.42 Million |
CA$2.11 Million ≈ $1.52 Million |
0.114x | +8673.40% |
| 2020-09-30 | CA$6.62 Million ≈ $4.79 Million |
CA$8.57K ≈ $6.20K |
0.001x | -69.27% |
| 2019-09-30 | CA$10.54 Million ≈ $7.62 Million |
CA$44.37K ≈ $32.10K |
0.004x | +108.12% |
| 2018-09-30 | CA$10.35 Million ≈ $7.49 Million |
CA$-537.00K ≈ $-388.46K |
-0.052x | -364.96% |
| 2017-09-30 | CA$15.17 Million ≈ $10.98 Million |
CA$297.05K ≈ $214.88K |
0.020x | -67.22% |
| 2016-09-30 | CA$15.29 Million ≈ $11.06 Million |
CA$913.31K ≈ $660.67K |
0.060x | +37.19% |
| 2015-09-30 | CA$13.68 Million ≈ $9.89 Million |
CA$595.40K ≈ $430.70K |
0.044x | +136.59% |
| 2014-09-30 | CA$9.84 Million ≈ $7.12 Million |
CA$-1.17 Million ≈ $-846.97K |
-0.119x | -258.89% |
| 2013-09-30 | CA$5.72 Million ≈ $4.14 Million |
CA$428.36K ≈ $309.87K |
0.075x | +117.64% |
| 2012-09-30 | CA$4.12 Million ≈ $2.98 Million |
CA$-1.75 Million ≈ $-1.27 Million |
-0.425x | -68.21% |
| 2011-09-30 | CA$5.15 Million ≈ $3.72 Million |
CA$-1.30 Million ≈ $-939.78K |
-0.252x | +21.42% |
| 2010-09-30 | CA$5.65 Million ≈ $4.09 Million |
CA$-1.81 Million ≈ $-1.31 Million |
-0.321x | +5.76% |
| 2009-09-30 | CA$6.41 Million ≈ $4.64 Million |
CA$-2.19 Million ≈ $-1.58 Million |
-0.341x | -32.97% |
| 2008-09-30 | CA$7.62 Million ≈ $5.51 Million |
CA$-1.95 Million ≈ $-1.41 Million |
-0.256x | +67.62% |
| 2007-09-30 | CA$2.28 Million ≈ $1.65 Million |
CA$-1.81 Million ≈ $-1.31 Million |
-0.792x | +25.75% |
| 2006-09-30 | CA$1.48 Million ≈ $1.07 Million |
CA$-1.58 Million ≈ $-1.14 Million |
-1.066x | -892.57% |
| 2005-09-30 | CA$2.77 Million ≈ $2.00 Million |
CA$372.31K ≈ $269.32K |
0.135x | -30.91% |
| 2004-09-30 | CA$2.28 Million ≈ $1.65 Million |
CA$444.57K ≈ $321.60K |
0.195x | +280.59% |
| 2003-09-30 | CA$1.99 Million ≈ $1.44 Million |
CA$-214.27K ≈ $-155.00K |
-0.108x | -315.02% |
| 2002-09-30 | CA$2.12 Million ≈ $1.53 Million |
CA$106.20K ≈ $76.82K |
0.050x | -70.95% |
| 2001-09-30 | CA$2.05 Million ≈ $1.48 Million |
CA$353.56K ≈ $255.76K |
0.173x | +334.02% |
| 2000-09-30 | CA$1.76 Million ≈ $1.28 Million |
CA$-130.02K ≈ $-94.06K |
-0.074x | +90.36% |
| 1999-09-30 | CA$1.70 Million ≈ $1.23 Million |
CA$-1.30 Million ≈ $-940.40K |
-0.765x | -25.49% |
| 1998-09-30 | CA$6.40 Million ≈ $4.63 Million |
CA$-3.90 Million ≈ $-2.82 Million |
-0.609x | -2337.50% |
| 1997-09-30 | CA$8.00 Million ≈ $5.79 Million |
CA$-200.00K ≈ $-144.68K |
-0.025x | -- |
About Microbix Biosystems Inc.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays… Read more